FDA Outlines Steps For Changing Drug Safety Controls
The U.S. Food and Drug Administration on Monday explained how changes to the so-called risk evaluation and mitigation strategies of prescription drugs should be reported, its latest effort to clarify muddled...To view the full article, register now.
Already a subscriber? Click here to view full article